BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23293726)

  • 21. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
    Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
    Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
    Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.
    Figueiredo P; Donato M; Urbano M; Goulão H; Gouveia H; Sofia C; Leitão M; Freitas D
    Int J Colorectal Dis; 2009 Apr; 24(4):441-50. PubMed ID: 18769883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
    Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
    Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biology and diagnosis of aberrant crypt foci.
    Lopez-Ceron M; Pellise M
    Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histomorphology of aberrant crypt foci in colorectal carcinoma.
    Norlida AO; Phang KS
    Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of aberrant crypt foci.
    Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
    Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of aberrant crypt foci. A surgical approach.
    Shpitz B; Hay K; Medline A; Bruce WR; Bull SB; Gallinger S; Stern H
    Dis Colon Rectum; 1996 Jul; 39(7):763-7. PubMed ID: 8674368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and quantification of aberrant crypt foci and microadenomas in the human colon.
    Roncucci L; Stamp D; Medline A; Cullen JB; Bruce WR
    Hum Pathol; 1991 Mar; 22(3):287-94. PubMed ID: 1706308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
    Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
    N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant crypt foci in patients with colorectal cancer.
    Roncucci L; Modica S; Pedroni M; Tamassia MG; Ghidoni M; Losi L; Fante R; Di Gregorio C; Manenti A; Gafa L; Ponz de Leon M
    Br J Cancer; 1998 Jun; 77(12):2343-8. PubMed ID: 9649156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
    Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
    Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in subjects with hereditary nonpolyposic and sporadic colon rectal cancer.
    Ramírez-Ramírez MA; Sobrino-Cossío S; de la Mora-Levy JG; Hernández-Guerrero A; Macedo-Reyes Vde J; Maldonado-Martínez HA; Alonso-Larraga JO; Ramírez-Solis ME
    J Gastrointest Cancer; 2012 Jun; 43(2):209-14. PubMed ID: 21744313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
    Higurashi T; Ashikari K; Tamura S; Saigusa Y; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Kessoku T; Hosono K; Yoneda M; Nakajima A
    Cancer Prev Res (Phila); 2022 Oct; 15(10):661-668. PubMed ID: 36083855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
    Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
    Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.
    Seike K; Koda K; Oda K; Kosugi C; Shimizu K; Nishimura M; Shioiri M; Takano S; Ishikura H; Miyazaki M
    Am J Gastroenterol; 2006 Jun; 101(6):1362-9. PubMed ID: 16771962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
    Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
    Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of aberrant crypt foci and microadenomas in human colon.
    Roncucci L; Medline A; Bruce WR
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats.
    Mohania D; Kansal VK; Kruzliak P; Kumari A
    Rejuvenation Res; 2014 Aug; 17(4):325-33. PubMed ID: 24524423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.